Literature DB >> 20123431

Treating the diseased superficial femoral artery.

Jerry M Gibbs1, Constantino S Peña, James F Benenati.   

Abstract

Vascular disease involving the superficial femoral artery (SFA) is common. Once the decision to treat the SFA is made, the benefits and limitations of angioplasty and stents must be applied to each specific patient. Additionally, the potential role of covered stents as well as drug eluting stents must be considered.

Entities:  

Mesh：

Year:  2010        PMID： 20123431     DOI： 10.1053/j.tvir.2009.10.005

Source DB:  PubMed          Journal:  Tech Vasc Interv Radiol        ISSN： 1557-9808


  2 in total

1.  SUrgical versus PERcutaneous Bypass: SUPERB-trial; Heparin-bonded endoluminal versus surgical femoro-popliteal bypass: study protocol for a randomized controlled trial.

Authors:  Mare M A Lensvelt; Suzanne Holewijn; Wilbert M Fritschy; Otmar R M Wikkeling; Laurens A van Walraven; Bas M Wallis de Vries; Clark J Zeebregts; Michel M P J Reijnen
Journal:  Trials       Date:  2011-07-18       Impact factor: 2.279

2.  Computational Modeling to Predict Fatigue Behavior of NiTi Stents: What Do We Need?

Authors:  Elena Dordoni; Lorenza Petrini; Wei Wu; Francesco Migliavacca; Gabriele Dubini; Giancarlo Pennati
Journal:  J Funct Biomater       Date:  2015-05-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.